1 SweisR, BillerJ. Systemic complications of spinal cord injury [J]. Curr Neurol Neurosci Rep, 2017, 17(2): 8. 2 HallerJ, BiceM, LawrenceB. Mediating the secondary effects of spinal cord injury through optimization of key physiologic parameters [J]. J Am Acad Orthop Surg, 2016, 24(3): 160-171. 3 HiltonB J, MoulsonA J, TetzlaffW. Neuroprotection and secondary damage following spinal cord injury: concepts and methods [J]. Neurosci Lett, 2017, 652: 3-10. 4 Yrj?nheikkiJ, Kein?nenR, PellikkaM, et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia [J]. Proc Natl Acad Sci U S A, 1998, 95(26): 15769-15774. 5 ShultzR B, ZhongY. Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury [J]. Neural Regen Res, 2017, 12(5): 702-713. 6 BadhiwalaJ H, AhujaC S, FehlingsM G. Time is spine: a review of translational advances in spinal cord injury [J]. J Neurosurg Spine, 2018, 30(1): 1-18. 7 Garrido-MesaN, ZarzueloA, GálvezJ. Minocycline: far beyond an antibiotic [J]. Br J Pharmacol, 2013, 169(2): 337-352. 8 CunhaB A, BaronJ, CunhaC B. Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations [J]. Eur J Clin Microbiol Infect Dis, 2018, 37(1): 15-20. 9 ZhouY Q, LiuD Q, ChenS P, et al. Minocycline as a promising therapeutic strategy for chronic pain [J]. Pharmacol Res, 2018, 134: 305-310. 10 GoldL S, DhawanS, WeissJ, et al. A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: results of 2 randomized, double-blind, phase 3 studies [J]. J Am Acad Dermatol, 2019, 80(1): 168-177. 11 FatimaG, SharmaV P, DasS K, et al. Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease [J]. Spinal Cord, 2015, 53(1): 3-6. 12 VisavadiyaN P, PatelS P, VanrooyenJ L, et al. Cellular and subcellular oxidative stress parameters following severe spinal cord injury [J]. Redox Biol, 2016, 8: 59-67. 13 ArasM, AltasM, MotorS, et al. Protective effects of minocycline on experimental spinal cord injury in rats [J]. Injury, 2015, 46(8): 1471-1474. 14 SonmezE, KabatasS, OzenO, et al. Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat [J]. Spine, 2013, 38(15): 1253-1259. 15 KarsyM, HawrylukG. Pharmacologic management of acute spinal cord injury [J]. Neurosurg Clin N Am, 2017, 28(1): 49-62. 16 SavitskayaM A, OnishchenkoG E. Mechanisms of apoptosis [J]. Biochemistry, 2015, 80(11): 1393-1405. 17 ChenD, ZengW, FuY, et al. Bone marrow mesenchymal stem cells combined with minocycline improve spinal cord injury in a rat model [J]. Int J Clin Exp Pathol, 2015, 8(10): 11957-11969. 18 PinkernelleJ, FansaH, EbmeyerU, et al. Prolonged minocycline treatment impairs motor neuronal survival and glial function in organotypic rat spinal cord cultures [J]. PLoS One, 2013, 8(8): e73422. 19 MeratiZ, FarshadA, FarzinpourA, et al. Anti-apoptotic effects of minocycline on ram epididymal spermatozoa exposed to oxidative stress [J]. Theriogenology, 2018, 114: 266-272. 20 RustR, KaiserJ. Insights into the dual role of inflammation after spinal cord injury [J]. J Neurosci, 2017, 37(18): 4658-4660. 21 KongX, GaoJ. Macrophage polarization: a key event in the secondary phase of acute spinal cord injury [J]. J Cell Mol Med, 2017, 21(5): 941-954. 22 GenselJ C, ZhangB. Macrophage activation and its role in repair and pathology after spinal cord injury [J]. Brain Res, 2015, 1619(14): 1-11. 23 ZhouX, HeX, RenY. Function of microglia and macrophages in secondary damage after spinal cord injury [J]. Neural Regen Res, 2014, 9(20): 1787-1795. 24 KobayashiK, ImagamaS, OhgomoriT, et al. Minocycline selectively inhibits M1 polarization of microglia [J]. Cell Death Dis, 2013, 4(3): e525. 25 PapaS, RossiF, FerrariR, et al. Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury [J]. ACS Nano, 2013, 7(11): 9881-9895. 26 PapaS, CaronI, ErbaE, et al. Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury [J]. Biomaterials, 2016, 75: 13-24. 27 CashaS, ZygunD, McgowanM D, et al. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury [J]. Brain, 2012, 135(4): 1224-1236. 28 Monaco E A 3rd , WeinerG M, FriedlanderR M. Randomized-controlled trial of minocycline for spinal cord injury shows promise [J].Neurosurgery, 2013, 72(2): N17-N19. 29 AhujaC S, FehlingsM. Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury [J]. Stem Cells Transl Med, 2016, 5(7): 914-924. 30 WangZ, NongJ, ShultzR B, et al. Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury [J]. Biomaterials, 2017, 112: 62-71. 31 Sharif-AlhoseiniM, KhormaliM, RezaeiM, et al. Animal models of spinal cord injury: a systematic review [J]. Spinal Cord, 2017, 55(8): 714-721. 32 UlndreajA, BadnerA, FehlingsM G. Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury [J]. F1000 Res, 2017, 6: 1907. 33 MartinA R, AleksanderekI, Cohen-AdadJ, et al. Translating state-of-the-art spinal cord MRI techniques to clinical use: a systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI [J]. Neuroimage Clin, 2015, 10: 192-238. 34 CashaS, RiceT, StirlingD P, et al. Cerebrospinal fluid biomarkers in human spinal cord injury from a phase II minocycline trial [J]. J Neurotrauma, 2018, 35(16): 1918-1928. 35 YousefifardM, SarveazadA, BabahajianA, et al. Potential diagnostic and prognostic value of serum and cerebrospinal fluid biomarkers in traumatic spinal cord injury: a systematic review [J]. J Neurochem, 2019, 149(3): 317-330. 36 BinS, ZhouN, PanJ, et al. Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats [J]. Drug Dev Ind Pharm, 2017, 43(6): 1033-1041. 37 SilvaT, SilvaJ C, ColacoB, et al. In vivo tissue response and antibacterial efficacy of minocycline delivery system based on polymethyl methacrylate bone cement [J]. J Biomater Appl, 2018, 33(3): 380-391. 38 WangX J, PengC H, ZhangS, et al. Polysialic acid-based micelles promote neural regeneration in spinal cord injury therapy [J]. Nano Lett, 2019, 19(2): 829-838. |